Shilpa Medicare Ltd. — Investor Relations & Filings
Shilpa Medicare Ltd. is a research-led organization specializing in the development, manufacture, and commercialization of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. The company maintains a significant focus on the oncology segment, producing a wide range of high-potency anti-cancer drugs. Its capabilities extend to diverse therapeutic areas, including ophthalmology, dermatology, and biosimilars. Shilpa Medicare operates manufacturing facilities compliant with international regulatory standards such as the USFDA and EU-GMP. The organization emphasizes complex chemistry and advanced drug delivery systems, offering a portfolio that includes oral solids, injectables, and transdermal patches. Through its R&D infrastructure, the company provides contract research and manufacturing services to global partners, supporting the lifecycle of generic and innovative pharmaceutical products.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Change in Management | 2026-04-23 | English | |
| Retirement | 2026-04-22 | English | |
| Updates | 2026-04-09 | English | |
| Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-04-06 | English | |
| Disclosure under SEBI Takeover Regulations | 2026-04-06 | English | |
| Trading Window | 2026-03-25 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 42173394 | Change in Management | 2026-04-23 | English | ||
| 42176384 | Retirement | 2026-04-22 | English | ||
| 42164373 | Updates | 2026-04-09 | English | ||
| 42203907 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-04-06 | English | ||
| 42209820 | Disclosure under SEBI Takeover Regulations | 2026-04-06 | English | ||
| 42185637 | Trading Window | 2026-03-25 | English | ||
| 42179337 | Amalgamation/Merger | 2026-03-17 | English | ||
| 42162766 | Amalgamation/Merger | 2026-03-05 | English | ||
| 42186101 | Press Release | 2026-02-24 | English | ||
| 42167625 | Copy of Newspaper Publication | 2026-02-19 | English | ||
| 42212132 | General Updates | 2026-02-14 | English | ||
| 42252959 | General Updates | 2026-02-13 | English | ||
| 42242152 | Analysts/Institutional Investor Meet/Con. Call Updates | 2026-02-10 | English | ||
| 42278684 | Analysts/Institutional Investor Meet/Con. Call Updates | 2026-02-06 | English | ||
| 42279242 | General Updates | 2026-02-06 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Shilpa Medicare Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/62243/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=62243 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=62243 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=62243 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 62243}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Shilpa Medicare Ltd. (id: 62243)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.